BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38235079)

  • 1. Tuning of TRAIL clustering on the surface of nanoscale liposomes by phase separation.
    Zhang Z; King MR
    Nanoscale Adv; 2024 Jan; 6(2):402-405. PubMed ID: 38235079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage-based particles carrying the TNF-related apoptosis-inducing ligand (TRAIL) gene for targeted delivery in hepatocellular carcinoma.
    Sittiju P; Wudtiwai B; Chongchai A; Hajitou A; Kongtawelert P; Pothacharoen P; Suwan K
    Nanoscale; 2024 Mar; 16(13):6603-6617. PubMed ID: 38470366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale Organization of TRAIL Trimers using DNA Origami to Promote Clustering of Death Receptor and Cancer Cell Apoptosis.
    Ma N; Cheng K; Feng Q; Liu G; Liang J; Ma X; Chen Z; Lu Y; Wang X; He W; Xu H; Wu S; Zou J; Shi Q; Nie G; Zhao X
    Small; 2023 Jun; 19(23):e2206160. PubMed ID: 36890776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
    J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cells.
    De Miguel D; Gallego-Lleyda A; Anel A; Martinez-Lostao L
    Leuk Res; 2015 Jun; 39(6):657-66. PubMed ID: 25882551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells.
    De Miguel D; Gallego-Lleyda A; Galan-Malo P; Rodriguez-Vigil C; Marzo I; Anel A; Martinez-Lostao L
    Clin Transl Oncol; 2015 Aug; 17(8):657-67. PubMed ID: 25967100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.
    Clodi K; Wimmer D; Li Y; Goodwin R; Jaeger U; Mann G; Gadner H; Younes A
    Br J Haematol; 2000 Nov; 111(2):580-6. PubMed ID: 11122106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Phase Separation in Vesicles Enhances TRAIL-Mediated Cytotoxicity.
    Vu TQ; Peruzzi JA; Sant'Anna LE; Roth EW; Kamat NP
    Nano Lett; 2022 Apr; 22(7):2627-2634. PubMed ID: 35298184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy.
    Chinnaiyan AM; Prasad U; Shankar S; Hamstra DA; Shanaiah M; Chenevert TL; Ross BD; Rehemtulla A
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1754-9. PubMed ID: 10677530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L; Zongyuan Y; Cheng G; Lingyun Z; Guilian Y; Wei G
    Cancer Sci; 2014 May; 105(5):520-7. PubMed ID: 24612139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micelle-in-Liposomes for Sustained Delivery of Anticancer Agents That Promote Potent TRAIL-Induced Cancer Cell Apoptosis.
    Zhang Z; Patel SB; King MR
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors.
    Chang R; Fu R; Huang Y; Zhang J; Feng C; Wang R; Yan H; Li G; Chu X; Yuan F; Jia D; Li J
    Mol Pharm; 2023 Jun; 20(6):2864-2875. PubMed ID: 37134184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer.
    Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Qian Y; Zhang L; Ma H; Jiang X
    Int J Nanomedicine; 2012; 7():1449-60. PubMed ID: 22619505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell death.
    Linderoth E; Pilia G; Mahajan NP; Ferby I
    J Biol Chem; 2013 Nov; 288(46):32922-31. PubMed ID: 24085293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Kazhdan I; Marciniak RA
    Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Anti-Tumor Activity of Novel Highly Bioactive Liposome-Bound TRAIL in Breast Cancer Cells.
    De Miguel D; Gallego-Lleyda A; Ayuso JM; Pawlak A; Conde B; Ochoa I; Fernández LJ; Anel A; Martinez-Lostao L
    Recent Pat Anticancer Drug Discov; 2016; 11(2):197-214. PubMed ID: 26924736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combating Cancer Stem-Like Cell-Derived Resistance to Anticancer Protein by Liposome-Mediated Acclimatization Strategy.
    Shen S; Lin S; Chen Y; Zhang Y; He Y; Xu X; Feng Y; Lu Y; Mo R
    Nano Lett; 2022 Mar; 22(6):2419-2428. PubMed ID: 35254834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
    Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
    Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes decorated with Apo2L/TRAIL overcome chemoresistance of human hematologic tumor cells.
    De Miguel D; Basáñez G; Sánchez D; Malo PG; Marzo I; Larrad L; Naval J; Pardo J; Anel A; Martinez-Lostao L
    Mol Pharm; 2013 Mar; 10(3):893-904. PubMed ID: 23331277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.